Fast Five Quiz: Progression of Follicular Lymphoma

Emmanuel C. Besa, MD


November 10, 2021

The Follicular Lymphoma International Prognostic Index (FLIPI) considers five independent predictors of poorer survival: age > 60 years, hemoglobin < 12 g/dL, higher than normal serum LDH, Ann Arbor stage III/IV, and more than four involved nodal areas. The presence of zero or one, two, or three or more adverse factors categorizes a patient as having low, intermediate, or high-risk disease, respectively. Established prognostic indices do not incorporate duration of response to initial therapy.

Other indices include FLIPI2 and GELF (Groupe d'Etude des Lymphomes Folliculaires).

Learn more about prognostic factors in FL.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.